FDA continues to investigate possible Gilenya link to PML
Posted: Mon Oct 21, 2013 12:17 am
FDA continues to investigate possible MS drug Gilenya link to brain infection death
The FDA is continuing to investigate a possible link between the multiple sclerosis drug Gilenya (fingolimod) and a case of a rare brain infection in a European patient.
The patient took the drug for nearly 8 months before being diagnosed with the brain infection. The FDA issued an alert at the end of August to inform the public of its investigation....... Read More - http://www.ms-uk.org/gilenya
The FDA is continuing to investigate a possible link between the multiple sclerosis drug Gilenya (fingolimod) and a case of a rare brain infection in a European patient.
The patient took the drug for nearly 8 months before being diagnosed with the brain infection. The FDA issued an alert at the end of August to inform the public of its investigation....... Read More - http://www.ms-uk.org/gilenya